New Delhi, Sept 02: Dabur Pharma Ltd has put in place an initial six-member board to provide strategic inputs and direction to the new company that will run the Rs 183.8 crore pharmaceutical business of Dabur India. The board members are Anand Burman, Amit Burman, P D Narang, Ajay Vij, Rama Mukherji and P S Srinivasan, a company statement said here.
The company proposes to strengthen the board with the induction of independent directors within next three months.
"The new pharma company will have identical shareholding pattern as in Dabur India Ltd and is expected to be listed by the end of third quarter on stock exchanges after the Delhi High Court grants its approval," P D Narang, group director, Dabur India, was quoted as saying.
The board of directors of Dabur India had decided to demerge its pharma division into a separate company in May this year.
Bureau Report